Insider: Eisner Mark EVP and Chief Medical Officer - Vir Biotechnology, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 154,024 | 0 | 154,024 |
| Value | $1,388,526.36 | $0.00 | $1,388,526.36 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/25/2026 | DDS | 1,889 | Direct | COM | $9.82 | $18,549.98 | 154,024 |
| 02/24/2026 | DDS | 1,616 | Direct | COM | $9.53 | $15,404.68 | 155,913 |
| 02/23/2026 | DDS | 2,089 | Direct | COM | $7.45 | $15,568.90 | 157,529 |
| 07/17/2025 | DDS | 3,586 | Direct | COM | $5.47 | $19,629.05 | 104,618 |
| 07/15/2025 | DDS | 6,796 | Direct | COM | $5.47 | $37,161.89 | 108,204 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research